What a great presentation!  Very well explains what management is attempting to achieve along with some idea of anticipated timelines.  Exciting stuff. BTI seems to have all the bases covered, very promising technology, very high quality in management, BoD and advisory board.

Nice add with the mention of how BTI favourably stacks up with the competition, especially in light of the fact that in the case of Denali their market cap is currently about $1.8B USD.  I believe they are early clinical but gives an indication of BTI's market potential.